Applications Published 23 August 2000

Published: 26-Feb-2001

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Luteinising hormone antagonosts useful for treatment of estrogen deficiencies, or as a contraceptive
    Novo Nordisk 1028690*

  • Uses of D-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells
    LVMH Recherche 1028705*

  • Buffered drug formulations for transdermal electrotransort delivery
    Alza Corp 1028706*

  • Sustained release ophthalmic compsns containing water soluble medicaments
    Insite Visign Inc 1028707*

  • Topical compsns for prostagaldin E1 Delivery
    Nexmed Holdings 1028708*

  • Novel once-a-day controlled release sulphonylurea formulation
    Edward Mendell 1028709*

  • Topical compsns for NSAID drug delivery
    Nexmed Holding 1028710*

  • Method for producing liposomes
    Beiersdorf Aktiengesellschaft 1028711*

  • Solid solution beadlet
    Shire Laboratories 1028712*

  • A process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating compsn
    Dow Chemical 1028713*

  • Vitamin compsn
    RP Scherer Holdings 1028714*

  • Dosage compsn for nasal delivery and method of use of the same
    University of Maryland, Baltimore 1028715*

  • Method for treating and preventing heart failure and ventricular dilation
    Warner-Lambert 1028716*

  • Unsubstituted polydiallylamine for treating hyppercholesterolemia
    Geltex Pharmaceuticals 1028717*

  • Extended release formulation containing venlafaxin
    American Home Products 1028718*

  • Treatment of attention deficit hyperactivity disorder and narcolepsy
    RP Scherer 1028719*

  • Methods, compsns and kits for enhancing female sexual desire and repsonsiveness
    Asivi 1028720*

  • (N,N')-bis(sulphonyl) hydrazines useful as antineoplastic agents
    Yale University 1028721*

  • Pharmaceutically active compsn containing artemisinine and/or a derivative of artemisinine
    Mepha 1028722*

  • Stabilised ascorbic acid, compsn, and method of use
    Sunsmart 1028723*

  • Transdermal delivery of 3,4-diarylchromans
    Novo Nordisk 1028724*

  • Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear
    Otogene AG 1028725*

  • Method and compsn for treatment of sexual dysfunction
    Vaysman, Pytor; Vaisman, Jakov 1028726*

  • Skin penetration enhancing compsns
    Aberdeen University 1028727*

  • Useof quinapril for treating myocardial ischaemia and angina
    Warner-Lambert 1028728*

  • Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds
    ASTA Medica 1028729*

  • Compns of lipid lowering agents
    Janssen Pharmaceutica 1028730*

  • Stable antiandrogenic gel compsn
    Schering Corp 1028731*

  • Use of selected phytostenol esters for producing hypocholesteraemic preparations
    Cognis Deutschland 1028732*

  • (Specific) steady-state R-typpe Ca2+ channel blockers and use thereof
    Universite de Sherbrooke 1028734*

  • Therapeutic methods comprising use of a neuregulin
    Cambridge Neurosciences 1028735*

  • Human mesenchymal stem cells from peripheral blood
    Osiris Therapeutics 1028737*

  • Use of cytokines and mitogens to inhibit pathological immune responses
    The University of Southern California 1028738*

  • Use of protein H as cytostatic agent
    Actinova 1028739*

  • Enhanced opening of abnormal brain tissue capillaries
    The Regents of the University of California 1028740*

  • Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
    Ontogeny 1028741*

  • Host-derived proteins binding HCV; medical, diagnostic and purification use
    Innogenetics 1028742*

  • Treatment and diagnosis of infertility using TGF(beta) or activin
    Luminis Pty 1028743*

  • Neuronal uses of BMP-11
    Genetics Institute 1028744*

  • Interferon immunotherapy
    Mayo Foundation for Medical Education 1028745*

  • Method for producing IGF-1 sustained-release formulations
    Chiron Corp 1028746*

  • Compsns providing for increased IGF-1 solubility
    Chiron Corp 1028748*

  • Enterococcus antigens and vaccines
    Nabi 1028749*

  • Multivalent vaccines
    Aventis Pasteur 1028750*

  • Methods and compsns comprising glycoprotein glycoforms
    Genentech 1028751*

  • Platelet substitutes and conjugation methods suitable for their preparation
    Quadrant Healthcare 1028752*

  • Delivery of poly(ethylene glycol)-conjugated molecules from degradable hydrogels
    Shearwater Polymers 1028753*

  • Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells
    The Trustees of the University of Pennsylvania 1028754*

  • A method for the reduction of oxygenated compounds of rhenium or technetium
    Nycomed Amersham 1028755*

  • Water soluble paclitaxel derivatives
    PG-TXL Company 1028756*

  • Methods for treating prostate cancer using radioactive compounds
    Micro Therapeutics 1028758*

  • Compounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
    University of Pittsburgh 1028941*

  • Dipeptide nitriles
    Novartis 1028942*

  • Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
    Ortho-McNeil 102943*

  • Fluorinated naphthalene derivatives and their use in liquid crystal mixtures
    Aventis Research and Technologies 1028944*

  • Substituted pyridine compounds as anti-inflammatory agents
    Amgen 1028945*

  • Indazole bioisostere replacement of catechol in therapeutically active compounds
    Pfizer Products 1028946*

  • H3 receptor ligands of the phenyl-alkyl-imidazoles type
    Schering Corp 1028947*

  • Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents
    Warner-Lambert 1028950*

  • Aromatic heterocyclic compounds as anti-inflammatory agents
    Boehringer Ingelheim Pharmaceuticals 1028953*

  • Substituted imidazoles useful in the treatment of inflammatory diseases
    Ortho-McNeil Pharmaceuticals 1028954*

  • Pyrimidinone compounds and pharmaceutical compsns containing them
    SmithKline Beecham 1028955*

  • Piperidine derivatives and their use as tachykinin antagonists
    Merck Sharp and Dohme 1028957*

  • Arylpiperazines as serotonin reuptake inhibitors and 5-HT1D alpha antagonists
    Eli Lilly 1028958*
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now